Outcomes in Relapsed Graves' Disease Patients Following Radioiodine or Prolonged Low Dose of Methimazole Treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Outcomes in Relapsed Graves' Disease Patients Following Radioiodine or Prolonged Low Dose of Methimazole Treatment

Published:2015-12 Issue:12 Volume:25 Page:1282-1290
ISSN:1050-7256
Container-title:Thyroid
language:en
Short-container-title:Thyroid

Author:

Villagelin Danilo¹²,Romaldini João H.¹³,Santos Roberto B.¹,Milkos Ana B.B.P.³,Ward Laura S.²

Affiliation:

1. Endocrinology and Metabolism, School of Medicine, Pontifical University Catholic of Campinas, Campinas, Brazil.

2. Laboratory of Cancer Molecular Genetics, School of Medicine Sciences, University of Campinas (UNICAMP), Campinas, Brazil.

3. Endocrinology, Hospital Servidor Público Estado de São Paulo, IAMSPE, São Paulo, Brazil.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/thy.2015.0195

Reference41 articles.

1. Case Selection and Restrictions Recommended to Patients with Hyperthyroidism in South America

2. The Management of Hyperthyroidism Due to Graves' Disease in Japan in 1988.

3. A 2011 Survey of Clinical Practice Patterns in the Management of Graves' Disease

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Approach to the Patient Considering Long-term Antithyroid Drug Therapy for Graves’ Disease;The Journal of Clinical Endocrinology & Metabolism;2024-07-09

2. Selenium and Prebiotics as Adjunctive Therapies in Treatment of Graves’ Disease;The Global Burden of Disease and Risk Factors - Understanding and Management;2024-07-03

3. Statins and thyroid eye disease (TED): a systematic review;Endocrine;2024-01-09

4. Risk of recurrence at the time of withdrawal of short- or long-term methimazole therapy in patients with Graves’ hyperthyroidism: a randomized trial and a risk-scoring model;Endocrine;2024-01-02

5. The Origin of Antithyroid Drugs;Thyroid®;2023-12-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3